Debra Walden
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Debra Walden's research focuses on the health outcomes of extremely preterm infants, particularly those enrolled in the Preterm Erythropoietin Neuroprotection Trial (PENUT). Her work has investigated the impact of erythropoietin on kidney-related outcomes and the association between term equivalent brain magnetic resonance imaging and later developmental outcomes in this vulnerable population. Walden has also examined the effects of transfusions on neurodevelopmental outcomes and the relationship between iron supplementation and bronchopulmonary dysplasia risk in extremely low gestational age newborns. Her recent publications include studies on urinary biomarkers and chronic kidney disease in neonates, as well as mortality rates in a cohort of extremely preterm infants.
Metrics
- h-index: 5
- Publications: 6
- Citations: 144
Selected Publications
-
Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates (2023)
-
Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns (2022)
-
Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial (2021)
Collaboration Network
Top Collaborators
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Similar Researchers
Based on overlapping research topics